|
Volumn 353, Issue 9151, 1999, Pages
|
Interferon beta treatment for multiple sclerosis.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
BETA1A INTERFERON;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
DISEASE COURSE;
ECONOMICS;
HEALTH CARE COST;
QUALITY ADJUSTED LIFE YEAR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
RANDOMIZED CONTROLLED TRIALS;
DISEASE PROGRESSION;
HEALTH CARE COSTS;
QUALITY-ADJUSTED LIFE YEARS;
|
EID: 0033528171
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)75166-7 Document Type: Letter |
Times cited : (6)
|
References (0)
|